{
    "body": "List FDA approved treatments for androgenetic allopecia", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24170634", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12410672", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20300365", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20426708", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15099321", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21061765", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20689478"
    ], 
    "ideal_answer": [
        "Recently, in addition to the two currently approved U.S. Food and Drug Administration (FDA) medications (minoxidil and finasteride), a novel device was FDA-approved for the treatment of hair loss, the laser hair comb."
    ], 
    "exact_answer": [
        [
            "Minoxidil"
        ], 
        [
            "Finasteride"
        ], 
        [
            "Laser hair comb"
        ]
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000505", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006201", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018859"
    ], 
    "type": "list", 
    "id": "5324d0169b2d7acc7e000022", 
    "snippets": [
        {
            "offsetInBeginSection": 530, 
            "offsetInEndSection": 774, 
            "text": "Topical minoxidil 2%-5% 1 mL twice daily or finasteride 1 mg daily are recommended as first line treatments, followed by the use of Food and Drug Administration-cleared HairMax LaserComb\u00ae in patients who do not respond to first line modalities.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24170634", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 505, 
            "offsetInEndSection": 722, 
            "text": "Recently, in addition to the two currently approved U.S. Food and Drug Administration (FDA) medications (minoxidil and finasteride), a novel device was FDA-approved for the treatment of hair loss, the laser hair comb.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21061765", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 330, 
            "offsetInEndSection": 489, 
            "text": "In addition, low-level light therapy (LLLT) has recently been approved by the United States Food and Drug Administration (FDA) for the treatment of hair loss. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20689478", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 460, 
            "offsetInEndSection": 681, 
            "text": "Currently there are two U.S. Food and Drug Administration (FDA)-approved agents that promote hair regrowth: over-the-counter topical minoxidil solution for men and women and prescription oral finasteride tablets for men. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410672", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 824, 
            "offsetInEndSection": 1043, 
            "text": "Topical monoxidil and oral finasteride are commonly in use and have FDA approval for the treatment of male androgenetic alopecia; dutasteride, a type I and II 5-alpha-reductase inhibitor, is on hold in Phase III trials.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20426708", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 227, 
            "offsetInEndSection": 315, 
            "text": "The only FDA-approved dermatological indication of finasteride is androgenetic alopecia.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20300365", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 12, 
            "offsetInEndSection": 111, 
            "text": "Finasteride (Propecia) was approved by the FDA in 1998 for treating men with androgenetic alopecia.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15099321", 
            "endSection": "abstract"
        }
    ]
}